Skip to content

Hematological Diseases Cohort in Northwest China——Clinical Cohorts, Multi-omics Genomic Landscape and Exploration of Biological Mechanisms

Hematological Diseases Cohort in Northwest China——Clinical Cohorts, Multi-omics Genomic Landscape and Exploration of Biological Mechanisms - Hematological Diseases Cohort in Northwest China

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500110911
Enrollment
Unknown
Registered
2025-10-22
Start date
2025-11-01
Completion date
Unknown
Last updated
2025-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hematological Diseases

Interventions

case group:None

Sponsors

Department of Hematology, Xijing Hospital, Air Force Military Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
No minimum to 100 Years

Inclusion criteria

Inclusion criteria: Starting from January 1, 2000, for patients diagnosed with hematopoietic stem cell deficiency syndromes, multiple myeloma, leukemia, myelodysplastic syndromes, myeloproliferative neoplasms, lymphomas, coagulopathies, hematological genetic disorders, who have undergone hematopoietic stem cell transplantation or other hematological system-related conditions: 1. Clinical cohort: Collect demographic data, diagnostic and therapeutic information, prognostic indicators, and healthcare expenditure details from electronic medical records. 2. Multi-omics genomic landscape characterization: Obtain biological specimens, including bone marrow aspirates, biopsy tissues, peripheral blood, cerebrospinal fluid, etc. For invasive analyses only residual specimens from routine clinical testing, as per established guidelines, are to be collected without additional procedures; for non-invasive samples such as feces and buccal swabs, longitudinal sampling will be performed according to specific experimental protocols. Obtain informed consent and document participant agreement.

Exclusion criteria

Exclusion criteria: 1. Due to multiple factors, comprehensive longitudinal follow-up data for the subjects could not be secured. 2. Substance dependence, including alcohol and illicit drugs, impairs participants' adherence to study protocols. 3. Based on the investigators' assessment, certain conditions may pose safety risks or compromise participant compliance. 4. The subjects declined to provide informed consent for participation.

Design outcomes

Primary

MeasureTime frame
Overall survival;Progression-free survival;

Secondary

MeasureTime frame
Response rate;Minimal residual disease;Quality of life;

Countries

China

Contacts

Public ContactHailong Tang

Xijing Hospital, Air Force Military Medical University

thl19880713@163.com+86 135 7242 8500

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026